732 reports of this reaction
7.2% of all VARENICLINE reports
#1 most reported adverse reaction
SNEEZING is the #1 most commonly reported adverse reaction for VARENICLINE, manufactured by Oyster Point Pharma, Inc.. There are 732 FDA adverse event reports linking VARENICLINE to SNEEZING. This represents approximately 7.2% of all 10,186 adverse event reports for this drug.
Patients taking VARENICLINE who experience sneezing should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SNEEZING is moderately reported among VARENICLINE users, representing a notable but not dominant share of adverse events.
In addition to sneezing, the following adverse reactions have been reported for VARENICLINE:
The following drugs have also been linked to sneezing in FDA adverse event reports:
SNEEZING has been reported as an adverse event in 732 FDA reports for VARENICLINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SNEEZING accounts for approximately 7.2% of all adverse event reports for VARENICLINE, making it one of the most commonly reported side effect.
If you experience sneezing while taking VARENICLINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.